Xenotransplantation becoming reality
To bridge the gap between organ demand and supply, xenotransplantation has long been considered as a realistic option for end-stage organ failure. Early this year this promise became reality for David Bennett Sr., the first patient whose own failing heart was replaced with a xeno-pig heart. To get h...
Gespeichert in:
| Veröffentlicht in: | Transgenic research 2022-06, Vol.31 (3), p.391-398 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 398 |
|---|---|
| container_issue | 3 |
| container_start_page | 391 |
| container_title | Transgenic research |
| container_volume | 31 |
| creator | Fischer, Konrad Schnieke, Angelika |
| description | To bridge the gap between organ demand and supply, xenotransplantation has long been considered as a realistic option for end-stage organ failure. Early this year this promise became reality for David Bennett Sr., the first patient whose own failing heart was replaced with a xeno-pig heart. To get here has been a rollercoaster ride of physiological hurdles seemingly impossible to overcome, technological breakthroughs and ethical and safety concerns. It started in 1984, with Stephanie Fae Beauclair, also known as baby Fae, receiving a baboon heart, which allowed her to survive for another 30 days. For ethical reasons primate work was soon abandoned in favour of the pig. But increased phylogenetic distance also brought with it an increased immunological incompatibility. It has been the development of ever more sophisticated genetic engineering tools, which brought down the physiological barriers, enabled humanisation of porcine organs and helped addressing safety concerns. This renewed the confidence in xenotransplantation, brought new funding opportunities and resulted finally in the first in human trial. |
| doi_str_mv | 10.1007/s11248-022-00306-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9135885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2664792711</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-2384aae0d9e13385036c8cc066b44a47cb3c5fd06d3ddd66eb3c437cfa758f123</originalsourceid><addsrcrecordid>eNp9kUtLAzEUhYMotlb_gAsp6MLNaN6PjSDFFxTcKLgLaSZTp0yTmkwt_femttbHwlUI9zsn9-QAcIzgBYJQXCaEMJUFxLiAkEBeLHZAFzFBCkW43AVdqDgupESqAw5SmkCYZZLsgw5hjDKuUBecvTgf2mh8mjXGt6atg--PnA3T2o_70ZmmbpeHYK8yTXJHm7MHnm9vngb3xfDx7mFwPSwsFbQtMJHUGAdL5RAhkkHCrbQWcj6i1FBhR8SyqoS8JGVZcu7ynRJhKyOYrBAmPXC19p3NR1NXWufzZo2exXpq4lIHU-vfE1-_6nF41woRJiXLBucbgxje5i61elon65oczYV50phzKhQWCGX09A86CfPoc7wVpYSQXNFM4TVlY0gpumq7DIJ6VYJel6BzCfqzBL3IopOfMbaSr1_PAFkDKY_82MXvt_-x_QBoEpMD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2669778694</pqid></control><display><type>article</type><title>Xenotransplantation becoming reality</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Fischer, Konrad ; Schnieke, Angelika</creator><creatorcontrib>Fischer, Konrad ; Schnieke, Angelika</creatorcontrib><description>To bridge the gap between organ demand and supply, xenotransplantation has long been considered as a realistic option for end-stage organ failure. Early this year this promise became reality for David Bennett Sr., the first patient whose own failing heart was replaced with a xeno-pig heart. To get here has been a rollercoaster ride of physiological hurdles seemingly impossible to overcome, technological breakthroughs and ethical and safety concerns. It started in 1984, with Stephanie Fae Beauclair, also known as baby Fae, receiving a baboon heart, which allowed her to survive for another 30 days. For ethical reasons primate work was soon abandoned in favour of the pig. But increased phylogenetic distance also brought with it an increased immunological incompatibility. It has been the development of ever more sophisticated genetic engineering tools, which brought down the physiological barriers, enabled humanisation of porcine organs and helped addressing safety concerns. This renewed the confidence in xenotransplantation, brought new funding opportunities and resulted finally in the first in human trial.</description><identifier>ISSN: 0962-8819</identifier><identifier>EISSN: 1573-9368</identifier><identifier>DOI: 10.1007/s11248-022-00306-w</identifier><identifier>PMID: 35545691</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Animal Genetics and Genomics ; Animals ; Biomedical and Life Sciences ; Biomedical Engineering/Biotechnology ; Commentary ; Ethics ; Genetic Engineering ; Genetic Engineering - methods ; Heart ; Humans ; Life Sciences ; Molecular Medicine ; Phylogeny ; Physiology ; Plant Genetics and Genomics ; Primates ; Swine - genetics ; Transgenics ; Transplantation, Heterologous - methods ; Xenografts ; Xenotransplantation</subject><ispartof>Transgenic research, 2022-06, Vol.31 (3), p.391-398</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-2384aae0d9e13385036c8cc066b44a47cb3c5fd06d3ddd66eb3c437cfa758f123</citedby><cites>FETCH-LOGICAL-c474t-2384aae0d9e13385036c8cc066b44a47cb3c5fd06d3ddd66eb3c437cfa758f123</cites><orcidid>0000-0002-5761-9635</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11248-022-00306-w$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11248-022-00306-w$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35545691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fischer, Konrad</creatorcontrib><creatorcontrib>Schnieke, Angelika</creatorcontrib><title>Xenotransplantation becoming reality</title><title>Transgenic research</title><addtitle>Transgenic Res</addtitle><addtitle>Transgenic Res</addtitle><description>To bridge the gap between organ demand and supply, xenotransplantation has long been considered as a realistic option for end-stage organ failure. Early this year this promise became reality for David Bennett Sr., the first patient whose own failing heart was replaced with a xeno-pig heart. To get here has been a rollercoaster ride of physiological hurdles seemingly impossible to overcome, technological breakthroughs and ethical and safety concerns. It started in 1984, with Stephanie Fae Beauclair, also known as baby Fae, receiving a baboon heart, which allowed her to survive for another 30 days. For ethical reasons primate work was soon abandoned in favour of the pig. But increased phylogenetic distance also brought with it an increased immunological incompatibility. It has been the development of ever more sophisticated genetic engineering tools, which brought down the physiological barriers, enabled humanisation of porcine organs and helped addressing safety concerns. This renewed the confidence in xenotransplantation, brought new funding opportunities and resulted finally in the first in human trial.</description><subject>Animal Genetics and Genomics</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering/Biotechnology</subject><subject>Commentary</subject><subject>Ethics</subject><subject>Genetic Engineering</subject><subject>Genetic Engineering - methods</subject><subject>Heart</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Molecular Medicine</subject><subject>Phylogeny</subject><subject>Physiology</subject><subject>Plant Genetics and Genomics</subject><subject>Primates</subject><subject>Swine - genetics</subject><subject>Transgenics</subject><subject>Transplantation, Heterologous - methods</subject><subject>Xenografts</subject><subject>Xenotransplantation</subject><issn>0962-8819</issn><issn>1573-9368</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtLAzEUhYMotlb_gAsp6MLNaN6PjSDFFxTcKLgLaSZTp0yTmkwt_femttbHwlUI9zsn9-QAcIzgBYJQXCaEMJUFxLiAkEBeLHZAFzFBCkW43AVdqDgupESqAw5SmkCYZZLsgw5hjDKuUBecvTgf2mh8mjXGt6atg--PnA3T2o_70ZmmbpeHYK8yTXJHm7MHnm9vngb3xfDx7mFwPSwsFbQtMJHUGAdL5RAhkkHCrbQWcj6i1FBhR8SyqoS8JGVZcu7ynRJhKyOYrBAmPXC19p3NR1NXWufzZo2exXpq4lIHU-vfE1-_6nF41woRJiXLBucbgxje5i61elon65oczYV50phzKhQWCGX09A86CfPoc7wVpYSQXNFM4TVlY0gpumq7DIJ6VYJel6BzCfqzBL3IopOfMbaSr1_PAFkDKY_82MXvt_-x_QBoEpMD</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Fischer, Konrad</creator><creator>Schnieke, Angelika</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5761-9635</orcidid></search><sort><creationdate>20220601</creationdate><title>Xenotransplantation becoming reality</title><author>Fischer, Konrad ; Schnieke, Angelika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-2384aae0d9e13385036c8cc066b44a47cb3c5fd06d3ddd66eb3c437cfa758f123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animal Genetics and Genomics</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering/Biotechnology</topic><topic>Commentary</topic><topic>Ethics</topic><topic>Genetic Engineering</topic><topic>Genetic Engineering - methods</topic><topic>Heart</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Molecular Medicine</topic><topic>Phylogeny</topic><topic>Physiology</topic><topic>Plant Genetics and Genomics</topic><topic>Primates</topic><topic>Swine - genetics</topic><topic>Transgenics</topic><topic>Transplantation, Heterologous - methods</topic><topic>Xenografts</topic><topic>Xenotransplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fischer, Konrad</creatorcontrib><creatorcontrib>Schnieke, Angelika</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transgenic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fischer, Konrad</au><au>Schnieke, Angelika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Xenotransplantation becoming reality</atitle><jtitle>Transgenic research</jtitle><stitle>Transgenic Res</stitle><addtitle>Transgenic Res</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>31</volume><issue>3</issue><spage>391</spage><epage>398</epage><pages>391-398</pages><issn>0962-8819</issn><eissn>1573-9368</eissn><abstract>To bridge the gap between organ demand and supply, xenotransplantation has long been considered as a realistic option for end-stage organ failure. Early this year this promise became reality for David Bennett Sr., the first patient whose own failing heart was replaced with a xeno-pig heart. To get here has been a rollercoaster ride of physiological hurdles seemingly impossible to overcome, technological breakthroughs and ethical and safety concerns. It started in 1984, with Stephanie Fae Beauclair, also known as baby Fae, receiving a baboon heart, which allowed her to survive for another 30 days. For ethical reasons primate work was soon abandoned in favour of the pig. But increased phylogenetic distance also brought with it an increased immunological incompatibility. It has been the development of ever more sophisticated genetic engineering tools, which brought down the physiological barriers, enabled humanisation of porcine organs and helped addressing safety concerns. This renewed the confidence in xenotransplantation, brought new funding opportunities and resulted finally in the first in human trial.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35545691</pmid><doi>10.1007/s11248-022-00306-w</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5761-9635</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0962-8819 |
| ispartof | Transgenic research, 2022-06, Vol.31 (3), p.391-398 |
| issn | 0962-8819 1573-9368 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9135885 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Animal Genetics and Genomics Animals Biomedical and Life Sciences Biomedical Engineering/Biotechnology Commentary Ethics Genetic Engineering Genetic Engineering - methods Heart Humans Life Sciences Molecular Medicine Phylogeny Physiology Plant Genetics and Genomics Primates Swine - genetics Transgenics Transplantation, Heterologous - methods Xenografts Xenotransplantation |
| title | Xenotransplantation becoming reality |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A14%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Xenotransplantation%20becoming%20reality&rft.jtitle=Transgenic%20research&rft.au=Fischer,%20Konrad&rft.date=2022-06-01&rft.volume=31&rft.issue=3&rft.spage=391&rft.epage=398&rft.pages=391-398&rft.issn=0962-8819&rft.eissn=1573-9368&rft_id=info:doi/10.1007/s11248-022-00306-w&rft_dat=%3Cproquest_pubme%3E2664792711%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2669778694&rft_id=info:pmid/35545691&rfr_iscdi=true |